Ocupharm News

Recently we were granted a EU H2020-SMEINST-1-2014 project for our Proposal No: 673533 – DryEye – SME-1. The project is about our biomarker for the diagnosis of dry-eye syndrome.


Additionally European Commission invited us to participate in the H2020 Project MSCA-RISE-2016/H2020-MSCA-RISE-2016
Proposal: 734907 — 3D NEONET since January 2017 and for the next 48 months. The Project is directed by the Irish University College of Dublin.


Starting from 1st of January 2020, we participate to another H2020 MSCA-ITN Project named ORBITAL, Proposal 813440. The Project is directed by the Irish Waterford Institute of Technology and we recruited a PhD student to prepare a Doctorate Thesis with the title Development of a novel biomarker cocktail for the diagnosis-screening of drug delivery and treatment efficacy in age-related ocular diseases

No hay comentarios aún.

Deje un comentario

Debe ser conectado para comentar una entrada